宮林 真未奈

Medicine & Life Sciences

1. Celiac Plexus 100%
2. Extrahepatic Bile Ducts 87%
3. Carcinoid Tumor 73%
4. Colonic Neoplasms 58%
5. Tomography 47%
6. Recurrence 40%
7. Pain 37%
8. Bile Ducts 35%
9. Neoplasm Metastasis 29%
10. trifluridine tipiracil 28%
11. Neoplasms 25%
12. Opioid Analgesics 21%
13. Adjuvant Chemotherapy 16%
14. tegafur-gimeracil-oteracil 14%
15. Cecal Neoplasms 13%
16. Carcinoembryonic Antigen 13%
17. Diatrizoate Meglumine 11%
18. Tegafur 11%
19. Biopsy 10%
20. Uracil 10%
21. Capecitabine 10%
22. Omentum 9%
23. Lymph Nodes 9%
24. Ileus 9%
25. Leucovorin 9%
26. Oxaliplatin 9%
27. Irinotecan 9%
28. Bupivacaine 9%
29. Bevacizumab 8%
30. Colectomy 8%
31. Choledochostomy 8%
32. Hepatectomy 8%
33. Magnetic Resonance Cholangiopancreatography 8%
34. Liver 8%
35. Back Pain 8%
36. Lymph Node Excision 7%
37. Chromogranin A 7%
38. Abdominal Pain 7%
39. Pancreaticoduodenectomy 6%
40. Ethanol 6%
41. Neuroendocrine Tumors 6%
42. Common Bile Duct 6%
43. Adenocarcinoma 6%
44. Rectal Neoplasms 5%
45. Hematoxylin 5%
46. Eosine Yellowish-(YS) 5%
47. Quality of Life 5%
48. Carbohydrates 5%
49. Cell Biology 5%